MENU
ABOS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Acumen Pharmaceuticals (ABOS) Ownership - Who owns Acumen Pharmaceuticals?
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease... Show more
Profile
Industry
N/A
Address
427 Park Street
Phone
+1 434 297-1000
Employees
52
Web
https://www.acumenpharm.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
65.42M
P/E Ratio
N/A
Total Cash
200.34M
Projected Growth
N/A
Total Debt
28.47M
Revenue
N/A
Risk (Beta)
0.01
Dividend Yield
N/A
Total Cash/Share
3.31
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ABOS
Capitalization
65.4M
P/E Ratio
N/A
Risk (Beta)
0.01
Dividend Yield
N/A
Total Cash
200M
Total Cash/Share
3.31
Total Debt
28.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
217M
P/B Ratio
0.36
Cash Flow
N/A
Earnings
-1.38
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
10.43
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-77.89M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-29.52
Shares Held By Institutions
93.1M
Shares Outstanding - Current
60.6M
Total Liabilities
49.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-37.209
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
427 Park Street
Phone
+1 434 297-1000
Employees
52
Web
https://www.acumenpharm.com